Pathophysiological microenvironments in oral candidiasis

Research output: Contribution to journalReviewResearchpeer-review

Standard

Pathophysiological microenvironments in oral candidiasis. / Jørgensen, Mette Rose.

In: APMIS, 2024.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Jørgensen, MR 2024, 'Pathophysiological microenvironments in oral candidiasis', APMIS. https://doi.org/10.1111/apm.13412

APA

Jørgensen, M. R. (2024). Pathophysiological microenvironments in oral candidiasis. APMIS. https://doi.org/10.1111/apm.13412

Vancouver

Jørgensen MR. Pathophysiological microenvironments in oral candidiasis. APMIS. 2024. https://doi.org/10.1111/apm.13412

Author

Jørgensen, Mette Rose. / Pathophysiological microenvironments in oral candidiasis. In: APMIS. 2024.

Bibtex

@article{7b215336e8f64834b428ca8a179b8a12,
title = "Pathophysiological microenvironments in oral candidiasis",
abstract = "Oral candidiasis (OC), a prevalent opportunistic infection of the oral mucosa, presents a considerable health challenge, particularly in individuals with compromised immune responses, advanced age, and local predisposing conditions. A considerable part of the population carries Candida in the oral cavity, but only few develop OC. Therefore, the pathogenesis of OC may depend on factors other than the attributes of the fungus, such as host factors and other predisposing factors. Mucosal trauma and inflammation compromise epithelial integrity, fostering a conducive environment for fungal invasion. Molecular insights into the immunocompromised state reveal dysregulation in innate and adaptive immunity, creating a permissive environment for Candida proliferation. Detailed examination of Candida species (spp.) and their virulence factors uncovers a nuanced understanding beyond traditional C. albicans focus, which embrace diverse Candida spp. and their strategies, influencing adhesion, invasion, immune evasion, and biofilm formation. Understanding the pathophysiological microenvironments in OC is crucial for the development of targeted therapeutic interventions. This review aims to unravel the diverse pathophysiological microenvironments influencing OC development focusing on microbial, host, and predisposing factors, and considers Candida resistance to antifungal therapy. The comprehensive approach offers a refined perspective on OC, seeking briefly to identify potential therapeutic targets for future effective management.",
keywords = "Candida virulence, dysbiosis, immunopathology, Oral mycobiome, therapeutic strategies",
author = "J{\o}rgensen, {Mette Rose}",
note = "Publisher Copyright: {\textcopyright} 2024 The Authors. APMIS published by John Wiley & Sons Ltd on behalf of Scandinavian Societies for Pathology, Medical Microbiology and Immunology.",
year = "2024",
doi = "10.1111/apm.13412",
language = "English",
journal = "A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica",
issn = "0903-4641",
publisher = "Wiley Online",

}

RIS

TY - JOUR

T1 - Pathophysiological microenvironments in oral candidiasis

AU - Jørgensen, Mette Rose

N1 - Publisher Copyright: © 2024 The Authors. APMIS published by John Wiley & Sons Ltd on behalf of Scandinavian Societies for Pathology, Medical Microbiology and Immunology.

PY - 2024

Y1 - 2024

N2 - Oral candidiasis (OC), a prevalent opportunistic infection of the oral mucosa, presents a considerable health challenge, particularly in individuals with compromised immune responses, advanced age, and local predisposing conditions. A considerable part of the population carries Candida in the oral cavity, but only few develop OC. Therefore, the pathogenesis of OC may depend on factors other than the attributes of the fungus, such as host factors and other predisposing factors. Mucosal trauma and inflammation compromise epithelial integrity, fostering a conducive environment for fungal invasion. Molecular insights into the immunocompromised state reveal dysregulation in innate and adaptive immunity, creating a permissive environment for Candida proliferation. Detailed examination of Candida species (spp.) and their virulence factors uncovers a nuanced understanding beyond traditional C. albicans focus, which embrace diverse Candida spp. and their strategies, influencing adhesion, invasion, immune evasion, and biofilm formation. Understanding the pathophysiological microenvironments in OC is crucial for the development of targeted therapeutic interventions. This review aims to unravel the diverse pathophysiological microenvironments influencing OC development focusing on microbial, host, and predisposing factors, and considers Candida resistance to antifungal therapy. The comprehensive approach offers a refined perspective on OC, seeking briefly to identify potential therapeutic targets for future effective management.

AB - Oral candidiasis (OC), a prevalent opportunistic infection of the oral mucosa, presents a considerable health challenge, particularly in individuals with compromised immune responses, advanced age, and local predisposing conditions. A considerable part of the population carries Candida in the oral cavity, but only few develop OC. Therefore, the pathogenesis of OC may depend on factors other than the attributes of the fungus, such as host factors and other predisposing factors. Mucosal trauma and inflammation compromise epithelial integrity, fostering a conducive environment for fungal invasion. Molecular insights into the immunocompromised state reveal dysregulation in innate and adaptive immunity, creating a permissive environment for Candida proliferation. Detailed examination of Candida species (spp.) and their virulence factors uncovers a nuanced understanding beyond traditional C. albicans focus, which embrace diverse Candida spp. and their strategies, influencing adhesion, invasion, immune evasion, and biofilm formation. Understanding the pathophysiological microenvironments in OC is crucial for the development of targeted therapeutic interventions. This review aims to unravel the diverse pathophysiological microenvironments influencing OC development focusing on microbial, host, and predisposing factors, and considers Candida resistance to antifungal therapy. The comprehensive approach offers a refined perspective on OC, seeking briefly to identify potential therapeutic targets for future effective management.

KW - Candida virulence

KW - dysbiosis

KW - immunopathology

KW - Oral mycobiome

KW - therapeutic strategies

U2 - 10.1111/apm.13412

DO - 10.1111/apm.13412

M3 - Review

C2 - 38571459

AN - SCOPUS:85189976625

JO - A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica

JF - A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica

SN - 0903-4641

ER -

ID: 388944464